Fidelity® Select Pharmaceuticals Port
Name
Price
Aum/Mkt Cap
YIELD & DIV
Exp Ratio
Watchlist
Vitals
YTD Return
-1.1%
1 yr return
1.3%
3 Yr Avg Return
15.0%
5 Yr Avg Return
10.9%
Net Assets
$802 M
Holdings in Top 10
73.4%
52 WEEK LOW AND HIGH
Expenses
OPERATING FEES
Expense Ratio 0.75%
SALES FEES
Front Load N/A
Deferred Load N/A
TRADING FEES
Turnover 29.00%
Redemption Fee N/A
Min Investment
Standard (Taxable)
$0
IRA
N/A
Fund Classification
Fund Type
Open End Mutual Fund
Investment Style
Health
Name
Price
Aum/Mkt Cap
YIELD & DIV
Exp Ratio
Watchlist
FPHAX - Profile
Distributions
- YTD Total Return -1.1%
- 3 Yr Annualized Total Return 15.0%
- 5 Yr Annualized Total Return 10.9%
- Capital Gain Distribution Frequency Semi-Annually
- Net Income Ratio 1.10%
- Dividend Yield 0.5%
- Dividend Distribution Frequency Semi-Annually
Fund Details
-
Legal NameFidelity® Select Pharmaceuticals Portfolio
-
Fund Family NameFidelity Investments
-
Inception DateJun 18, 2001
-
Shares OutstandingN/A
-
Share ClassNo Load
-
CurrencyUSD
-
Domiciled CountryUnited States
-
ManagerKarim Suwwan de Felipe
Fund Description
The fund normally invests at least 80% of assets in companies engaged in the research, development, manufacture, sale, or distribution of pharmaceuticals and drugs of all types. It invests in domestic and foreign issuers. The fund invests primarily in common stocks. It uses fundamental analysis of factors such as each issuer's financial condition and industry position, as well as market and economic conditions to select investments. The fund is non-diversified.
FPHAX - Performance
Return Ranking - Trailing
Period | FPHAX Return | Category Return Low | Category Return High | Rank in Category (%) |
---|---|---|---|---|
YTD | -1.1% | -26.9% | 25.3% | 8.42% |
1 Yr | 1.3% | -60.2% | 11.7% | 20.81% |
3 Yr | 15.0%* | -10.0% | 19.7% | 16.11% |
5 Yr | 10.9%* | -6.4% | 16.9% | 32.17% |
10 Yr | 12.5%* | 6.4% | 18.5% | 66.67% |
* Annualized
Return Ranking - Calendar
Period | FPHAX Return | Category Return Low | Category Return High | Rank in Category (%) |
---|---|---|---|---|
2021 | 0.2% | -79.9% | 24.2% | 54.34% |
2020 | 1.6% | -13.6% | 178.2% | 91.36% |
2019 | 21.0% | 3.8% | 63.8% | 49.66% |
2018 | 3.8% | -49.7% | 21.5% | 8.03% |
2017 | 8.9% | -59.8% | 54.4% | 82.96% |
Total Return Ranking - Trailing
Period | FPHAX Return | Category Return Low | Category Return High | Rank in Category (%) |
---|---|---|---|---|
YTD | -1.1% | -46.5% | 25.3% | 9.47% |
1 Yr | 1.3% | -60.2% | 28.3% | 24.08% |
3 Yr | 15.0%* | -13.2% | 20.0% | 16.56% |
5 Yr | 10.9%* | -6.4% | 16.9% | 31.85% |
10 Yr | 12.5%* | 6.4% | 18.5% | 65.89% |
* Annualized
Total Return Ranking - Calendar
Period | FPHAX Return | Category Return Low | Category Return High | Rank in Category (%) |
---|---|---|---|---|
2021 | 0.2% | -79.9% | 24.2% | 54.34% |
2020 | 1.6% | -13.6% | 178.2% | 91.36% |
2019 | 21.0% | 3.8% | 63.8% | 49.66% |
2018 | 4.4% | -49.7% | 22.2% | 7.30% |
2017 | 10.7% | -59.8% | 54.4% | 87.41% |
NAV & Total Return History
FPHAX - Holdings
Concentration Analysis
FPHAX | Category Low | Category High | FPHAX % Rank | |
---|---|---|---|---|
Net Assets | 802 M | 732 K | 46.2 B | 45.26% |
Number of Holdings | 74 | 21 | 473 | 46.63% |
Net Assets in Top 10 | 616 M | 2.18 K | 21.6 B | 32.21% |
Weighting of Top 10 | 73.42% | 12.3% | 80.8% | 1.44% |
Top 10 Holdings
- Eli Lilly and Co 14.33%
- AstraZeneca PLC ADR 12.36%
- Sanofi SA ADR 10.36%
- Bristol-Myers Squibb Co 9.80%
- Roche Holding AG 6.65%
- Johnson & Johnson 4.47%
- Royalty Pharma PLC Class A 4.45%
- Merck & Co Inc 4.00%
- Fidelity Revere Str Tr 3.84%
- Amgen Inc 3.81%
Asset Allocation
Weighting | Return Low | Return High | FPHAX % Rank | |
---|---|---|---|---|
Stocks | 99.07% | 85.37% | 106.13% | 47.12% |
Cash | 0.50% | -0.10% | 9.01% | 54.33% |
Other | 0.43% | -22.99% | 3.38% | 16.35% |
Preferred Stocks | 0.00% | 0.00% | 7.86% | 39.42% |
Convertible Bonds | 0.00% | 0.00% | 0.37% | 41.35% |
Bonds | 0.00% | 0.00% | 12.39% | 37.98% |
Stock Sector Breakdown
Weighting | Return Low | Return High | FPHAX % Rank | |
---|---|---|---|---|
Healthcare | 100.00% | 59.26% | 100.00% | 20.67% |
Utilities | 0.00% | 0.00% | 0.00% | 36.06% |
Technology | 0.00% | 0.00% | 22.69% | 41.35% |
Real Estate | 0.00% | 0.00% | 7.13% | 40.87% |
Industrials | 0.00% | 0.00% | 7.02% | 40.87% |
Financial Services | 0.00% | 0.00% | 1.85% | 50.96% |
Energy | 0.00% | 0.00% | 0.00% | 36.06% |
Communication Services | 0.00% | 0.00% | 9.11% | 39.42% |
Consumer Defense | 0.00% | 0.00% | 25.73% | 44.71% |
Consumer Cyclical | 0.00% | 0.00% | 14.20% | 39.90% |
Basic Materials | 0.00% | 0.00% | 14.83% | 57.21% |
Stock Geographic Breakdown
Weighting | Return Low | Return High | FPHAX % Rank | |
---|---|---|---|---|
US | 53.67% | 53.67% | 104.41% | 100.00% |
Non US | 45.40% | 0.00% | 45.40% | 0.48% |
FPHAX - Expenses
Operational Fees
FPHAX Fees (% of AUM) | Category Return Low | Category Return High | Rank in Category (%) | |
---|---|---|---|---|
Expense Ratio | 0.75% | 0.08% | 3.13% | 54.50% |
Management Fee | 0.52% | 0.00% | 1.25% | 24.74% |
12b-1 Fee | N/A | 0.00% | 1.00% | N/A |
Administrative Fee | N/A | 0.03% | 0.25% | N/A |
Sales Fees
FPHAX Fees (% of AUM) | Category Return Low | Category Return High | Rank in Category (%) | |
---|---|---|---|---|
Front Load | N/A | 0.00% | 5.75% | N/A |
Deferred Load | N/A | 1.00% | 5.00% | N/A |
Trading Fees
FPHAX Fees (% of AUM) | Category Return Low | Category Return High | Rank in Category (%) | |
---|---|---|---|---|
Max Redemption Fee | N/A | 1.00% | 2.00% | 70.73% |
Related Fees
Turnover provides investors a proxy for the trading fees incurred by mutual fund managers who frequently adjust position allocations. Higher turnover means higher trading fees.
FPHAX Fees (% of AUM) | Category Return Low | Category Return High | Rank in Category (%) | |
---|---|---|---|---|
Turnover | 29.00% | 0.00% | 238.00% | 24.34% |
FPHAX - Distributions
Dividend Yield Analysis
FPHAX | Category Low | Category High | FPHAX % Rank | |
---|---|---|---|---|
Dividend Yield | 0.48% | 0.00% | 8.66% | 47.42% |
Dividend Distribution Analysis
FPHAX | Category Low | Category High | Category Mod | |
---|---|---|---|---|
Dividend Distribution Frequency | Semi-Annually | Semi-Annually | Quarterly | Semi-Annually |
Net Income Ratio Analysis
FPHAX | Category Low | Category High | FPHAX % Rank | |
---|---|---|---|---|
Net Income Ratio | 1.10% | -2.54% | 1.92% | 6.29% |
Capital Gain Distribution Analysis
FPHAX | Category Low | Category High | Capital Mode | |
---|---|---|---|---|
Capital Gain Distribution Frequency | Semi-Annually | Annually | Annually | Annually |
Dividend Payout History
Date | Amount | Type |
---|---|---|
Apr 10, 2017 | $0.023 | OrdinaryDividend |
Dec 19, 2016 | $0.183 | OrdinaryDividend |
Apr 16, 2012 | $0.045 | OrdinaryDividend |
Dec 12, 2011 | $0.077 | OrdinaryDividend |
Apr 07, 2011 | $0.035 | OrdinaryDividend |
Dec 13, 2010 | $0.110 | OrdinaryDividend |
Apr 12, 2010 | $0.020 | OrdinaryDividend |
Dec 14, 2009 | $0.115 | OrdinaryDividend |
Apr 20, 2009 | $0.040 | OrdinaryDividend |
Dec 15, 2008 | $0.110 | OrdinaryDividend |
Apr 14, 2008 | $0.020 | OrdinaryDividend |
Dec 17, 2007 | $0.070 | OrdinaryDividend |
Apr 16, 2007 | $0.040 | OrdinaryDividend |
Dec 18, 2006 | $0.030 | OrdinaryDividend |
Apr 10, 2006 | $0.010 | OrdinaryDividend |
Dec 19, 2005 | $0.010 | OrdinaryDividend |
Apr 11, 2005 | $0.005 | OrdinaryDividend |
FPHAX - Fund Manager Analysis
Managers
Karim Suwwan de Felipe
Start Date
Tenure
Tenure Rank
Jul 01, 2017
4.92
4.9%
Karim Suwwan de Felipe is portfolio manager of Pharmaceuticals Portfolio, which he has managed since July 2017. Since joining Fidelity Investments in 2010, Mr. Suwwan de Felipe has worked as a research analyst and portfolio manager
Tenure Analysis
Category Low | Category High | Category Average | Category Mode |
---|---|---|---|
0.02 | 24.72 | 7.54 | 2.12 |